Sulfasalazine
REMEDYREPACK INC.
FULL PRESCRIBING INFORMATION: CONTENTS*
FULL PRESCRIBING INFORMATION
SULFASALAZINE DESCRIPTION
CLINICAL PHARMACOLOGY
PHARMACODYNAMICS
INDICATIONS & USAGE
SULFASALAZINE CONTRAINDICATIONS
WARNINGS
PRECAUTIONS, Laboratory Tests
PRECAUTIONS
INFORMATION FOR PATIENTS
LABORATORY TESTS
DRUG INTERACTIONS
PREGNANCY
<%0A%09%09%09%09%09%09%09> <%0A%09%09%09%09%09%09%09>NURSING MOTHERS
PEDIATRIC USE
SULFASALAZINE ADVERSE REACTIONS
OVERDOSAGE
DOSAGE & ADMINISTRATION
HOW SUPPLIED
REFERENCES
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION
Sulfasalazine
Sulfasalazine TABLET
Product Information
|
|
Product Type
|
Human prescription drug label |
Item Code (Source)
|
NDC:49349-178(NDC:0591-0796) |
|
Route of Administration
|
ORAL |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
|
Ingredient Name
|
Basis of Strength
|
Strength
|
|
SULFASALAZINE SULFASALAZINE |
|
500 mg
|
Product Characteristics
|
|
Color
|
Size
|
Imprint Code
|
Shape
|
|
yellow |
12 mm |
WATSON;796 |
ROUND |
Packaging
|
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
|
1 |
NDC:49349-178-02 |
30 in 1 BLISTER PACK |
|
|
Marketing Information
|
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
|
ANDA |
ANDA085828 |
2011-04-19 |
|
|
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
